BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 6769681)

  • 1. Ergot alkaloids: interaction with presynaptic dopamine receptors in the neostriatum and olfactory tubercles.
    Marek KL; Roth RH
    Eur J Pharmacol; 1980 Mar; 62(2-3):137-46. PubMed ID: 6769681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic prenatal haloperidol exposure: lack of effect on presynaptic dopamine autoreceptors.
    Scalzo FM; Newport GD; Gough BJ; Ali SF; Holson RR
    Neurotoxicology; 1989; 10(3):485-90. PubMed ID: 2516618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Presynaptic dopamine receptors: insensitivity to kainic acid and the development of supersensitivity following chronic haloperidol.
    Bannon MJ; Bunney EB; Zigun JR; Skirboll LR; Roth RH
    Naunyn Schmiedebergs Arch Pharmacol; 1980 Jun; 312(2):161-5. PubMed ID: 6772975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential action of bromocriptine on nigrostriatal versus mesolimbic dopaminergic neurons.
    Barton AC; Moore KE; Demarest KT
    J Neural Transm; 1987; 68(1-2):25-39. PubMed ID: 2879883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopaminergic neurons: an in vivo system for measuring drug interactions with presynaptic receptors.
    Walters JR; Roth RH
    Naunyn Schmiedebergs Arch Pharmacol; 1976 Dec; 296(1):5-14. PubMed ID: 13315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopamine receptor stimulating effects of chanoclavine analogues, tricyclic ergot alkaloids, in the brain.
    Watanabe H; Somei M; Sekihara S; Nakagawa K; Yamada F
    Jpn J Pharmacol; 1987 Dec; 45(4):501-6. PubMed ID: 3127619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The short- and long-term effects of haloperidol on rat central dopamine turnover.
    Tsutsumi T; Kojima H; Anraku S; Inanaga K
    Brain Res; 1982 Jan; 232(2):485-8. PubMed ID: 7188034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The interactions of bromocriptine and lergotrile with dopamine and alpha-adrenergic receptors.
    Lew JY; Hata F; Ohashi T; Goldstein M
    J Neural Transm; 1977; 41(2-3):109-21. PubMed ID: 21229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of some ergot alkaloids on dopamine receptors of molluscan smooth muscle.
    Ishii Y; Takayanagi I
    J Pharmacobiodyn; 1982 Sep; 5(9):748-50. PubMed ID: 7153848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apomorphine-haloperidol interactions: different types of antagonism in cortical and subcortical brain regions.
    Bacopoulos NG; Roth RH
    Brain Res; 1981 Feb; 205(2):313-9. PubMed ID: 7470869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simple method for evaluation of stimulatory effect of drugs on presynaptic dopamine receptors in mice.
    Watanabe H
    J Pharmacol Methods; 1985 Aug; 14(1):41-7. PubMed ID: 3928976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bromocriptine, a dopamine D(2) receptor agonist with the structure of the amino acid ergot alkaloids, induces neurite outgrowth in PC12 cells.
    Oda T; Kume T; Izumi Y; Takada-Takatori Y; Niidome T; Akaike A
    Eur J Pharmacol; 2008 Nov; 598(1-3):27-31. PubMed ID: 18835264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic haloperidol during development attenuates dopamine autoreceptor function in striatal and mesolimbic brain regions of young and older adult rats.
    Scalzo FM; Spear LP
    Psychopharmacology (Berl); 1985; 85(3):271-6. PubMed ID: 3923514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of ergot alkaloids with dopaminergic receptors in the rat striatum and nucleus accumbens.
    Spano PF; Trabucchi M
    Gerontology; 1978; 24 Suppl 1():106-14. PubMed ID: 618775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Demonstration of autoreceptors on dopamine neurons in different brain regions of rats treated with gammabutyrolactone.
    Andén NE; Grabowska-Andén M; Liljenberg B
    J Neural Transm; 1983; 58(3-4):143-52. PubMed ID: 6420514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anorectic effect of lisuride and other ergot derivatives in the rat.
    Carruba MO; Ricciardi S; Müller EE; Mantegazza P
    Eur J Pharmacol; 1980 Jun; 64(2-3):133-41. PubMed ID: 6105081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding interactions of ergot alkaloids with monoaminergic receptors in the brain.
    Goldstein M; Lew JY; Hata F; Lieberman A
    Gerontology; 1978; 24 Suppl 1():76-85. PubMed ID: 22480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoreceptors mediate the inhibition of dopamine synthesis by bromocriptine and lisuride in rats.
    Tissari AH; Rossetti ZL; Meloni M; Frau MI; Gessa GL
    Eur J Pharmacol; 1983 Aug; 91(4):463-8. PubMed ID: 6413231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential functional ontogeny of dopamine presynaptic receptor regulation.
    Shalaby IA; Dendel PS; Spear LP
    Brain Res; 1981 Jun; 227(3):434-9. PubMed ID: 7260651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential actions of dopamine agonists and antagonists on the gamma-butyrolactone-induced in mouse brain dopamine.
    Gianutsos G; Thornburg JE; Moore KE
    Psychopharmacology (Berl); 1976 Nov; 50(3):225-9. PubMed ID: 826966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.